The Mount Sinai Journal of Medicine

 


Volume 65 Number 5&6
October/November 1998
back to contents

Oral Cancer and Oral Effects of Anticancer Therapy 370
Andrei Barasch, D.M.D., M.D.Sc.1, Monika Safford, M.D.2, And Ellen Eisenberg, D.M.D.3
From the Departments of 1Dental Medicine and 2Medicine, New Jersey Dental School, University of Medicine and Dentistry of New Jersey, Newark, NJ, and 3Department of Oral Diagnosis, University of Connecticut School of Dental Medicine, Farmington, CT. 1Assistant Professor; 2Assistant Professor; 3Professor and Director of Oral Pathology.

Address correspondence to Andrei Barasch, D.M.D., M.D.Sc., University of Medicine and Dentistry of New Jersey, New Jersey Dental School, Room C 829, 110 Bergen Street, Newark, NJ 07103-2400.

ABSTRACT
The term "oral cancer" generally refers to squamous cell carcinoma of oral mucosal origin, which accounts for more than 90% of all malignancies of this location. Although a relatively uncommon disease in the United States, this malignancy is nonetheless important, as it accounts for significant morbidity and mortality. Approximately half of the estimated 30 thousand cases diagnosed annually in this country have a fatal outcome. Survivors of the surgical and medical management may suffer from sequelae of treatment ranging from pain and infection to partial or total disfigurement and loss of stomatognathic function. Such high morbidity and mortality are truly regrettable, since many of these malignancies are preventable. This article will review recent developments in the epidemiology, treatment and chemoprevention of oral squamous cell carcinoma as they relate to early diagnosis, and management of the oral cancer patient.

KEY WORDS
Mouth, cancer, chemotherapy, etiology, epidemiology, radiation


Mount Sinai School of Medicine MSSM Home Back Issues | Indexes | Search | Journal Home [title]